,10,19 This includes PD-L1:PD-1 and CD80/86:CTLA-4, which act to block inhibitory signaling between tumor cells and T cells and antigen-presenting cells (APCs) and T cells, respectively.20 This evidence concerns the gene CD80 and neoplasm.